Literature DB >> 28891851

Sphincter-Sparing Anal Fistula Repair: Are We Getting Better?

Jeremy Sugrue1, Nathalie Mantilla, Ariane Abcarian, Kunal Kochar, Slawomir Marecik, Vivek Chaudhry, Anders Mellgren, Johan Nordenstam.   

Abstract

BACKGROUND: Sphincter-sparing repairs are commonly used to treat anal fistulas with significant muscle involvement.
OBJECTIVE: The current study evaluates the trends and efficacy of sphincter-sparing repairs and determines risk factors for fistula recurrence. DESIGN AND SETTINGS: A retrospective review was performed at 3 university-affiliated teaching hospitals. PATIENTS: All 462 patients with cryptoglandular anal fistulas who underwent 573 sphincter-sparing repairs between 2005 and 2015 were included. Patients with Crohn's disease were excluded. MAIN OUTCOME MEASURES: The primary outcome was the rate of fistula healing defined as cessation of drainage with closure of the external opening. Risk factors for nonhealing were also analyzed.
RESULTS: Five hundred three sphincter-sparing repairs were analyzed, whereas 70 were lost to follow-up. Two hundred twenty sphincter-sparing repairs (44%) resulted in healing, 283 (56%) resulted in nonhealing with a median follow-up of 9 (range, 1-125) months. The median time to fistula recurrence was 3 (range, 0-75) months with 79% and 91% of recurrences noted within 6 and 12 months. Patients treated with a dermal advancement flap, rectal advancement flap, or ligation of the intersphincteric tract procedure were less likely to have a recurrence than patients treated with a fistula plug or fibrin glue (p < 0.001). Over time, there was a significantly increased use of the ligation of the intersphincteric tract procedure (p < 0.001) and a significantly decreased use of fistula plugs and fibrin glue (p < 0.001); healing rates improved accordingly. There were no significant differences in healing rates with respect to patient demographics, comorbidities, or fistula characteristics. LIMITATIONS: This study was limited by its retrospective design.
CONCLUSIONS: Healing rates following sphincter-sparing repairs of cryptoglandular anal fistulas are modest, but have improved over time with the use of better surgical techniques. In this study, ligation of the intersphincteric fistula tract and flaps were superior to fistula plugs and fibrin glue; the former procedures are therefore favored. See Video Abstract at http://links.lww.com/DCR/A391.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28891851     DOI: 10.1097/DCR.0000000000000885

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

1.  Fistulotomy and primary sphincteroplasty for anal fistula: long-term data on continence and patient satisfaction.

Authors:  F Litta; A Parello; V De Simone; U Grossi; R Orefice; C Ratto
Journal:  Tech Coloproctol       Date:  2019-09-19       Impact factor: 3.781

2.  Evaluation and management of perianal abscess and anal fistula: SICCR position statement.

Authors:  A Amato; C Bottini; P De Nardi; P Giamundo; A Lauretta; A Realis Luc; V Piloni
Journal:  Tech Coloproctol       Date:  2020-01-23       Impact factor: 3.781

3.  Fistula Laser Closure (FiLaC™) for fistula-in-ano-yet another technique with 50% healing rates?

Authors:  Andreas Nordholm-Carstensen; Helene Perregaard; Kikke Bartholin Hagen; Peter-Martin Krarup
Journal:  Int J Colorectal Dis       Date:  2021-04-21       Impact factor: 2.571

Review 4.  Benign Anorectal Disorder Management in Low-Resource Settings.

Authors:  Lucia Oliveira; Gonzalo Federico Hagerman Ruiz Galindo; Jorge Daniel Silva-Velazco
Journal:  Clin Colon Rectal Surg       Date:  2022-09-13

Review 5.  [Quality indicators in the treatment of anal fistulas].

Authors:  O Schwandner
Journal:  Chirurg       Date:  2019-04       Impact factor: 0.955

6.  The development of a cryptoglandular Anal Fistula Core Outcome Set (AFCOS): an international Delphi study protocol.

Authors:  A J H M Machielsen; N Iqbal; M L Kimman; K Sahnan; S O Adegbola; J Kleijnen; C J Vaizey; U Grossi; P J Tozer; S O Breukink
Journal:  United European Gastroenterol J       Date:  2020-03       Impact factor: 4.623

7.  Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a prospective case-control study.

Authors:  Yang Zhang; Min Ni; Chungen Zhou; Yehuang Wang; Yaxian Wang; Yang Shi; Jing Jin; Rui Zhang; Bin Jiang
Journal:  Stem Cell Res Ther       Date:  2020-11-10       Impact factor: 6.832

8.  Molecular differences of adipose-derived mesenchymal stem cells between non-responders and responders in treatment of  transphincteric perianal fistulas.

Authors:  Michaela Tencerova; Lilli Lundby; Steen Buntzen; Stig Norderval; Helene Tarri Hougaard; Bodil Ginnerup Pedersen; Moustapha Kassem
Journal:  Stem Cell Res Ther       Date:  2021-11-24       Impact factor: 6.832

9.  Stem cell injection for complex anal fistula in Crohn's disease: A single-center experience.

Authors:  Oliver Schwandner
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

10.  Adipose-Derived Stem Cells Are an Efficient Treatment for Fistula-in-ano of Japanese Rabbit.

Authors:  Xiao Qin; Peng Wang; Yongming Huang; Yansen Li; Min Chao; Wei Wang
Journal:  Stem Cells Int       Date:  2019-10-22       Impact factor: 5.443

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.